
Insulin Degludec Flextouch Coupons & Discount Card – Guaranteed Prices from $65.89
My prescription
Edit
3 solution pen-injectors 3ML of 200UNIT/ML, Insulin Degludec Flextouch (1 Pen)
Select pharmacy

CVS
$96.32
COUPON PRICE
Walgreens
$65.89
COUPON PRICE
Walmart
$70.91
COUPON PRICEInsulin Degludec Flextouch savings card
Show this card to your pharmacist
Walgreens
$65.89
BIN
ID
PCN
GRP
019876
LHE379D36C
CHIPPO
LHX
Powered by
More prescriptions for diabetes
More prescriptions for diabetes
Insulin Degludec Flextouch dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
5 solution pen-injectors 3ML of 100UNIT/ML | 1 Pen | $4.14 | $4.14 |
3 solution pen-injectors 3ML of 200UNIT/ML | 1 Pen | $65.89 | $65.89 |
Insulin Degludec Flextouch Side Effects
Common side effects:
- Reactions at the injection site
- Pain
- Redness
- Irritation
- Weight gain
Less common but important to monitor:
- Low blood sugar (hypoglycemia)
- High blood sugar
Serious side effects:
- Signs of low potassium
- Allergic reactions
Insulin Degludec Flextouch Interactions
Interactions with moderate risk that may require dose adjustment, closer monitoring, or timing changes:
- Beta-blockers (such as metoprolol, propranolol, timolol)
Is insulin degludec the same as Lantus?
Insulin degludec and Lantus are not the same. Insulin degludec is a long-acting insulin marketed under the brand name Tresiba, while Lantus is the brand name for insulin glargine, another long-acting insulin. Both are used to manage blood sugar levels in individuals with diabetes, but they have different formulations and durations of action.
Why is Tresiba so expensive?
The cost of Tresiba can be attributed to several factors. These include the research and development expenses involved in creating the medication, the costs associated with clinical trials, and the regulatory approval process. Additionally, the pricing may reflect the value it provides in terms of efficacy and convenience for patients. Market exclusivity and patent protection can also play a role in maintaining higher prices. Furthermore, manufacturing and distribution costs, as well as the pricing strategies of pharmaceutical companies, contribute to the overall expense.
What type of insulin is Tresiba Flextouch?
Tresiba Flextouch is a long-acting insulin. It is used to help control blood sugar levels in individuals with diabetes.
Is insulin degludec long or short acting?
Insulin degludec is a long-acting insulin.
What drugs should not be taken with Tresiba?
Tresiba (insulin degludec) may interact with several types of medications. It is important to be cautious with the following:1. Other Antidiabetic Medications: Combining with other insulin or antidiabetic drugs can increase the risk of hypoglycemia.2. Beta-Blockers: These can mask the symptoms of hypoglycemia, making it harder to recognize low blood sugar levels.3. ACE Inhibitors and Angiotensin II Receptor Blockers (ARBs): These can enhance the blood-glucose-lowering effect, increasing the risk of hypoglycemia.4. Corticosteroids and Diuretics: These may increase blood glucose levels, potentially requiring an adjustment in insulin dosage.5. Thyroid Hormones: These can affect insulin requirements.6. Monoamine Oxidase Inhibitors (MAOIs): These can potentiate the hypoglycemic effect of insulin.Patients should always consult with their healthcare provider before starting or stopping any medication while using Tresiba to ensure safe and effective management of their condition.